These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Retinal hyperreflective foci in Fabry disease. Atiskova Y; Rassuli R; Koehn AF; Golsari A; Wagenfeld L; du Moulin M; Muschol N; Dulz S Orphanet J Rare Dis; 2019 Dec; 14(1):296. PubMed ID: 31878969 [TBL] [Abstract][Full Text] [Related]
7. Computer-assisted evaluation of retinal vessel tortuosity in moderate-to-late preterm children. Raffa L; Abudawd O; Bugshan N; Fageeh S; Ramos L; Novo J; Rouco J; Ortega M Eur J Ophthalmol; 2023 Sep; 33(5):1874-1882. PubMed ID: 36775924 [TBL] [Abstract][Full Text] [Related]
8. Visual outcome, ocular findings, and visual quality of life in patients with Fabry disease. Nilsson M; Kolagari HT; Epstein D; Samolov B; Olsson M; Naess K; Oscarson M; Teaer Fahnehjelm K Ophthalmic Genet; 2022 Dec; 43(6):841-849. PubMed ID: 36325813 [TBL] [Abstract][Full Text] [Related]
9. Corneal densitometry: a potential indicator for early diagnosis of Fabry disease. Li S; Siggel R; Guo Y; Loreck N; Rokohl AC; Kurschat C; Heindl LM Graefes Arch Clin Exp Ophthalmol; 2021 Apr; 259(4):941-948. PubMed ID: 33258999 [TBL] [Abstract][Full Text] [Related]
10. Fabry disease and chemosis. Edwards JD; Bower KS; Brooks DB; Walter A Cornea; 2009 Feb; 28(2):224-7. PubMed ID: 19158572 [TBL] [Abstract][Full Text] [Related]
11. Diabetes and the tortuosity of vessels of the bulbar conjunctiva. Owen CG; Newsom RS; Rudnicka AR; Barman SA; Woodward EG; Ellis TJ Ophthalmology; 2008 Jun; 115(6):e27-32. PubMed ID: 18423868 [TBL] [Abstract][Full Text] [Related]
12. Autophagy-lysosome pathway alteration in ocular surface manifestations in Fabry disease patients. Marenco M; Segatto M; Sacchetti M; Mangiantini P; Giovannetti F; Plateroti R Orphanet J Rare Dis; 2022 Jul; 17(1):291. PubMed ID: 35870972 [TBL] [Abstract][Full Text] [Related]
13. Lower fractal dimension of retinal vessel for patients with Birdshot chorioretinopathy. Furnon L; Labarere J; Trucco E; Hogg S; MacGillivray T; Chiquet C Acta Ophthalmol; 2023 Jun; 101(4):392-402. PubMed ID: 36382575 [TBL] [Abstract][Full Text] [Related]
14. Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre. Nguyen TT; Gin T; Nicholls K; Low M; Galanos J; Crawford A Clin Exp Ophthalmol; 2005 Apr; 33(2):164-8. PubMed ID: 15807825 [TBL] [Abstract][Full Text] [Related]
15. Ocular manifestations of Fabry's disease: data from the Fabry Outcome Survey. Sodi A; Ioannidis AS; Mehta A; Davey C; Beck M; Pitz S Br J Ophthalmol; 2007 Feb; 91(2):210-4. PubMed ID: 16973664 [TBL] [Abstract][Full Text] [Related]
16. Ophthalmic experience over 10 years in an observational nationwide Danish cohort of Fabry patients with access to enzyme replacement. Fledelius HC; Sandfeld L; Rasmussen ÅK; Madsen CV; Feldt-Rasmussen U Acta Ophthalmol; 2015 May; 93(3):258-64. PubMed ID: 25487570 [TBL] [Abstract][Full Text] [Related]
17. Computer-aided analysis of middle cerebral artery tortuosity: association with aneurysm development. Kliś KM; Krzyżewski RM; Kwinta BM; Stachura K; Moskała M; Tomaszewski KA J Neurosurg; 2019 May; 130(5):1478-1484. PubMed ID: 29775150 [TBL] [Abstract][Full Text] [Related]
18. Ocular findings and their correlation with disease severity in Fabry disease in South-East Anatolia. Mete A; Dogan L; Ozcakmakci GB; Sayiner ZA; Gungor K Int Ophthalmol; 2023 Jul; 43(7):2301-2306. PubMed ID: 36595126 [TBL] [Abstract][Full Text] [Related]
19. QUANTIFICATION OF RETINAL VESSEL TORTUOSITY IN DIABETIC RETINOPATHY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY. Lee H; Lee M; Chung H; Kim HC Retina; 2018 May; 38(5):976-985. PubMed ID: 28333883 [TBL] [Abstract][Full Text] [Related]
20. Digital image analysis in retinopathy of prematurity: a comparison of vessel selection methods. Wilson CM; Wong K; Ng J; Cocker KD; Ells AL; Fielder AR J AAPOS; 2012 Jun; 16(3):223-8. PubMed ID: 22681937 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]